Rimini Street, Inc.

For the period ended Mar 31, 2026. Filed Apr 30, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 30, 2026

RMNI$5.53+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

ITEM 1. Financial Statements

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)

	March 31,	December 31,
	2026	2025
ASSETS
Current assets:
Cash and cash equivalents	$132,189	$119,974
Restricted cash, current	342	341
Accounts receivable, net of allowance of $1,783 and $1,443, respectively	95,746	136,866
Deferred contract costs, current	17,570	17,734
Prepaid expenses and other	28,286	25,447
Total current assets	274,133	300,362
Long-term assets:
Restricted cash, noncurrent	784	785
Property and equipment, net of accumulated depreciation and amortization of $23,952 and $23,822, respectively	9,879	10,239
Operating lease right-of-use assets	20,494	21,371
Deferred contract costs, noncurrent	24,087	24,436
Deposits and other	8,745	8,379
Deferred income taxes, net	58,979	57,540
Total assets	$397,101	$423,112
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Current maturities of long-term debt	$—	$4,031
Accounts payable	4,966	5,752
Accrued compensation, benefits and commissions	33,747	39,609
Other accrued liabilities	23,475	24,307
Operating lease liabilities, current	4,815	4,984
Deferred revenue, current	257,382	268,717
Total current liabilities	324,385	347,400
Long-term liabilities:
Long-term debt, net of current maturities	56,412	63,156
Deferred revenue, noncurrent	19,947	18,824
Operating lease liabilities, noncurrent	17,357	18,843
Other long-term liabilities	1,566	1,918
Total liabilities	419,667	450,141
Commitments and contingencies (Note 8)
Stockholders’ deficit:
Preferred stock; $0.0001 par value. Authorized 99,820 (excluding 180 shares of Series A Preferred Stock) no other series has been designated	—	—
Common stock; $0.0001 par value. Authorized 1,000,000 shares; issued and outstanding 92,133 and 91,603 shares, respectively	9	9
Additional paid-in capital	184,073	181,075
Accumulated other comprehensive loss	(5,509)	(5,613)
Accumulated deficit	(200,023)	(201,384)
Treasury stock, at cost; 137 and 137 shares, respectively	(1,116)	(1,116)
Total stockholders' deficit	(22,566)	(27,029)
Total liabilities and stockholders' deficit	$397,101	$423,112

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income

(In thousands, except per share amounts)

	Three Months EndedMarch 31,
	2026	2025
Revenue	$105,473	$104,204
Cost of revenue	43,208	40,670
Gross profit	62,265	63,534
Operating expenses:
Sales and marketing	38,636	34,255
General and administrative	17,850	17,531
Reorganization costs	407	462
Research and development	571	—
Litigation costs and related recoveries:
Professional fees and other costs of litigation	—	1,925
Litigation costs and related recoveries, net	—	1,925
Total operating expenses	57,464	54,173
Operating income	4,801	9,361
Non-operating income and (expenses):
Interest expense	(1,251)	(1,675)
Other income (expenses), net	(1,240)	(77)
Income before income taxes	2,310	7,609
Income taxes	(949)	(4,259)
Net income	1,361	3,350
Other comprehensive income
Foreign currency translation gain (loss)	(322)	674
Derivative instrument and other adjustments, net of tax	426	(983)
Comprehensive income	$1,465	$3,041
Net income per share attributable to common stockholders:
Basic	$0.01	$0.04
Diluted	$0.01	$0.04
Weighted average number of shares of Common Stock outstanding:
Basic	91,791	91,240
Diluted	93,918	93,320

Unaudited Condensed Consolidated Statements of Stockholders' Deficit

	Three Months Ended March 31,
	2026	2025
Common Stock, Shares
Beginning of period	91,603	91,120
Exercise of stock options for cash	124	2
Restricted and performance stock units vested	406	229
End of period	92,133	91,351
Total Stockholders' Deficit, beginning of period	$(27,029)	$(69,445)
Common Stock, Amount
Beginning of period	9	9
Exercise of stock options for cash	—	—
Restricted and performance stock units vested	—	—
End of period	9	9
Additional Paid-in Capital
Beginning of period	181,075	177,533
Stock based compensation expense	2,661	2,702
Exercise of stock options for cash	337	6
Restricted and performance stock units vested	—	—
End of period	184,073	180,241
Accumulated Other Comprehensive Loss
Beginning of period	(5,613)	(7,389)
Other comprehensive income (loss)	104	(309)
End of period	(5,509)	(7,698)
Accumulated Deficit
Beginning of period	(201,384)	(238,482)
Net income	1,361	3,350
End of period	(200,023)	(235,132)
Treasury Stock	(1,116)	(1,116)
Total Stockholders' Deficit, end of period	$(22,566)	$(63,696)

Unaudited Condensed Consolidated Statements of Cash Flows

	Three Months Ended March 31,
	2026	2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$1,361	$3,350
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	2,661	2,702
Depreciation and amortization	995	930
Accretion and amortization of debt discount and issuance costs	162	162
Deferred income taxes	(1,450)	2,464
Amortization and accretion related to operating right of use assets	1,350	1,191
Other	31	—
Changes in operating assets and liabilities:
Accounts receivable, net	41,369	57,491
Prepaid expenses, deposits and other	(2,833)	(1,166)
Deferred contract costs	513	2,030
Accounts payable	(779)	(431)
Accrued compensation and other accruals	(8,604)	(7,283)
Deferred revenue	(10,253)	(27,732)
Net cash provided by operating activities	24,523	33,708
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(648)	(895)
Net cash used in investing activities	(648)	(895)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on term loan borrowings	(10,938)	(938)
Principal payments on capital leases	—	(94)
Proceeds from exercise of employee stock options	337	6
Net cash used in financing activities	(10,601)	(1,026)
Effect of foreign currency translation changes	(1,059)	2,768
Net change in cash, cash equivalents and restricted cash	12,215	34,555
Cash, cash equivalents and restricted cash at beginning of period	121,100	89,222
Cash, cash equivalents and restricted cash at end of period	$133,315	$123,777

Unaudited Condensed Consolidated Statements of Cash Flows, Continued

	Three Months Ended March 31,
	2026	2025
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	$1,091	$1,513
Cash paid for income taxes	1,000	843
Cash paid for withholding taxes	968	766

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.